High pS63-c-Jun expression was correlated with advanced American Joint Committee on Cancer (AJCC) tumour node metastasis (TNM) stage and lymph node metastasis (Fig. 7d), and high CPT1A was also associated with lymph node metastasis (Fig. 7e). Here, JUN is linked to metastatic malignant neoplasm in the lymph nodes.